版权说明 操作指南
首页 > 成果 > 详情

Use of different ligand modification liposomes to evaluate the anti-liver tumor activity of cantharidin

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Zou, Manshu;Xu, Yilin;Lin, Peng;Zhou, Lili*;Xia, Xinhua
通讯作者:
Zhou, Lili;Xia, XH
作者机构:
[Xia, Xinhua; Xu, Yilin; Lin, Peng; Zhou, Lili; Zou, Manshu] Hunan Univ Chinese Med, Sch Pharm, Changsha, Peoples R China.
[Xia, Xinhua; Zhou, Lili; Zhou, LL; Xia, XH] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China.
通讯机构:
[Zhou, LL; Xia, XH ] H
Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China.
语种:
英文
关键词:
Cantharidin;anti-liver tumour activity;3-succinic-30-stearyl deoxyglycyrrhetinic acid;stearyl alcohol galactoside;delivery of bioactive monomer;ligand modification
期刊:
Journal of Liposome Research
ISSN:
0898-2104
年:
2023
卷:
33
期:
3
页码:
283-299
基金类别:
This work was supported by the National Science Foundation of China (No. 81573621), the Science and Technology Innovation Plan of Hunan Province (No. 2021RC4064), and the Natural Science Foundation of Hunan Province (Nos. 2022JJ40320 and 2022JJ40323).
机构署名:
本校为其他机构
院系归属:
药学院
摘要:
In this study, cantharidin(CTD), a bioactive terpenoid in traditional Chinese medicine cantharidin, was selected as a model component to construct novel nano liposome delivery systems for hepatocellular carcinoma therapy. Previous studies have shown that although cantharidin has definite curative effects on primary liver cancer, it is associated with numerous toxic and side effects. Therefore, based on the glycyrrhetinic acid (GA) binding site and the asialoglycoprotein receptor (ASGPR) on the hepatocyte membrane, the surface of CTD liposomes w...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com